Gene · 2913
Papers2,242
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,141 to 1,160 of 2,242
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Schizophrenia drug discovery and development in an evolving era: are new drug targets fulfilling expectations? | J Psychopharmacol | 2015 | 25586401 | PubTator, text mining | PubMed |
| Glutamate and dopamine in schizophrenia: an update for the 21st century. | J Psychopharmacol | 2015 | 25586400 | PubTator, text mining | PubMed |
| Metabotropic glutamate receptor 3 activation is required for long-term depression in medial prefrontal cortex and fear extinction. | Proc Natl Acad Sci U S A | 2015 | 25583490 | PubTator, text mining | PubMed |
| Neuronal activity patterns in the mediodorsal thalamus and related cognitive circuits are modulated by metabotropic glutamate receptors. | Neuropharmacology | 2015 | 25576798 | PubTator, text mining | PubMed |
| DeCoN: genome-wide analysis of in vivo transcriptional dynamics during pyramidal neuron fate selection in neocortex. | Neuron | 2015 | 25556833 | PubTator, text mining | PubMed |
| Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders. | Pharmacol Ther | 2015 | 25550231 | PubTator, text mining | PubMed |
| Further optimization of the M5 NAM MLPCN probe ML375: tactics and challenges. | Bioorg Med Chem Lett | 2015 | 25542588 | PubTator, text mining | PubMed |
| The NMDA receptor 'glycine modulatory site' in schizophrenia: D-serine, glycine, and beyond. | Curr Opin Pharmacol | 2015 | 25540902 | PubTator, text mining | PubMed |
| Therapeutic potential of group III metabotropic glutamate receptor ligands in pain. | Curr Opin Pharmacol | 2015 | 25498980 | PubTator, text mining | PubMed |
| Somatic mutations of the ATP1A1 gene and aldosterone-producing adenomas. | Mol Cell Endocrinol | 2015 | 25496839 | PubTator, text mining | PubMed |
| Group I and group II metabotropic glutamate receptor allosteric modulators as novel potential antipsychotics. | Curr Opin Pharmacol | 2015 | 25462291 | PubTator, text mining | PubMed |
| Molecular signatures of mood stabilisers highlight the role of the transcription factor REST/NRSF. | J Affect Disord | 2015 | 25451397 | PubTator, text mining | PubMed |
| Novel metabotropic glutamate receptor 2/3 antagonists and their therapeutic applications: a patent review (2005 - present). | Expert Opin Ther Pat | 2015 | 25435285 | PubTator, text mining | PubMed |
| Activation of mGlu3 metabotropic glutamate receptors enhances GDNF and GLT-1 formation in the spinal cord and rescues motor neurons in the SOD-1 mouse model of amyotrophic lateral sclerosis. | Neurobiol Dis | 2015 | 25434487 | PubTator, text mining | PubMed |
| Increased metabotropic glutamate 2/3 receptor binding in the perigenual anterior cingulate cortex of Cloninger type 2 alcoholics: a whole-hemisphere autoradiography study. | Alcohol Alcohol | 2015 | 25425009 | PubTator, text mining | PubMed |
| G protein-coupled receptors in stem cell maintenance and somatic reprogramming to pluripotent or cancer stem cells. | BMB Rep | 2015 | 25413305 | PubTator, text mining | PubMed |
| Schizophrenia genetics: building the foundations of the future. | Schizophr Bull | 2015 | 25394665 | PubTator, text mining | PubMed |
Relative contributions of presystemic and systemic peptidases to oral exposure of a novel metabotropic glutamate 2/3 receptor agonist (LY404039) after oral administration of prodrug pomaglumetad methionil (LY2140023). | J Pharm Sci | 2015 | 25382826 | PubTator, text mining | PubMed |
| Epigenetic upregulation of metabotropic glutamate receptor 2 in the spinal cord attenuates oestrogen-induced visceral hypersensitivity. | Gut | 2015 | 25378524 | PubTator, text mining | PubMed |
| Recent genetic findings in schizophrenia and their therapeutic relevance. | J Psychopharmacol | 2015 | 25315827 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2913/papers?page=58